Navigation Links
PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
Date:4/23/2008

1,231 1,473

Restructuring benefit (860) -

Total costs and expenses 272,002 225,144

Income from operations 22,721 15,475

Other income 352 292

Income before income taxes 23,073 15,767

Provision for income taxes 8,586 5,071

Effective tax rate 37.2% 32.2%

Minority interest expense (benefit) 301 (101)

Net income $14,186 $10,797

Earnings per common share:

Basic $0.25 $0.20

Diluted $0.25 $0.19

Shares used in computing earnings

per common share:

Basic 56,108 54,865

Diluted 57,765 56,220

Balance Sheet Information Preliminary

Mar 31, Dec 31, June 30,

2008 2007 2007

Billed accounts receivable, net $216,060 $221,476 $189,843

Unbilled accounts receivable, net 197,627 163,251 135,178

Deferred revenue (199,121) (200,093) (170,718)

Net receivables $214,566 $184,634 $154,303

Cash and marketable securities $53,313 $62,926 $96,677

Working capital $165,437 $108,877 $118,746

Total assets $859,638 $809,549 $680,013

Short-term borrowings $13,656 $60,453 $30,463

Long-term debt $38,443 $231 $277'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...EN,Italy,November24/PRNewswire/--HealthRoboticstod...ewithagroupofselected,investors.Thisrecentlyformed...RoboticsCanada,Inc.andwillmarket,install,andsuppor...ncludesthe,revolutionaryproductofferingsi.v.STATIO...aInc.willalsoprovideassistanceonan"asneeded,basis"...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeutic...tatthe21stAnnualPiperJaffrayHealthCareConference.T...kPalaceHotel. ,, CTIwillpresentonTuesday,Decemb...audiowebcastofCTI,spresentationwillbeavailableat w...orreplayafterwards. , ,PiperJaffrayHealthCareConf...
(Date:11/23/2009)...omputing promises ultra-fast communication, comput...information. But trying to use quantum states as c...siness. Now two physicists have shown, mathematica...ntum communication, while keeping the information ...e of Physical Review Letters and highlighted wit...
(Date:11/23/2009)...SISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioScie...ctdevelopmentcompanythatidentifiesandadvancesadive...iousstagesofdevelopment,todayreportedthatCytopia(A...uatingCYT387,apotent,orally-administeredJAK1/JAK2i...hester,Minnesota.AproposaltomergeCytopiaintoYMhasb...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...t. 14 Dr. Eliane Gluckman, recognized,as a pionee...transplantation, has joined the team at CORD:USE C...complished physician as Dr. Gluckman join our,team...ORD:USE," says Edward,Guindi M.D., President and C...recognized as the pioneering physician,who perform...
...t. 14 LI-COR Biosciences introduces a,new, novel ...he Odyssey(R),Infrared Imaging system. The Odyssey...stained and fluoresces in the 700 and 800 nm chann... for use with polyacrylamide gels,and can be used ...ring,electrophoresis, to monitor transfer efficien...
...f the Office of National Drug Control Policy to Mo...icines Become Bad Drugs, FRAZER, Pa., Oct. 14 Ce...t is embarking on a national educational,program d...s, caregivers,and the public about the importance ... opioid medications. The initiative, When Good Med...
Other Biology Technology:CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 2CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 3LI-COR Introduces the Odyssey(R) Two-Color NIR Fluorescent Protein Molecular Weight Marker 2Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications 2
(Date:11/24/2009)... that keep weakened and flabby arteries from colla...nths, those stents are no longer needed -- once th...ry. Previously, doctors had no choice but to leave...Aviv University,s Department of Biomedical Enginee...form that carries drugs where they,re needed, then...
(Date:11/24/2009)...N ROUGE Antarctica has long held secrets of the e... recently, there has been very little information ...miles of ice for millions of years. Now, a team of... have been funded to the tune of $10 million doll... get to the bottom of things literally. These sci...
(Date:11/23/2009)...NATINew research presents strong evidence that the...th outdoor traffic-related pollution and indoor en...one or the other exposure alone. , Environment...ti (UC) College of Medicine have shown that childr...particles and indoor endotoxin during early life a...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Bullies have harassed 14 percent of workers over past 6 months 8718 1Bullies have harassed 14 percent of workers over past 6 months 8718 2WaveSense Reduces Diabetes Testing Cost by 50 25 47934 1WaveSense Reduces Diabetes Testing Cost by 50 25 47934 2The Rev Michael J OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees 47932 1The Rev Michael J OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees 47932 2
..., 2009 Gov. Rick Perry today announced the awardi...uston through the Texas Emerging Technology Fund (...ruited a top hormones researcher and his team to c...neration pharmaceuticals and medical technologies ...d The Methodist Hospital Research Institute (TMHRI...
...searchers at The University of Texas at Austin, in... completed the first high-resolution CT scan of th...an ancestor who lived 3.2 million years ago. , L...miere exhibit organized by the Houston Museum of N...thropology in the College of Liberal Arts, led the...
..., PhD, a professor of history at NJIT and a former...ent for the Humanities (NEH) Fellowship to edit a ... eighteenth-century Scottish writer. Boswell was b...her,s research focuses on the thought and culture ... will publish the book in its Research Series of t...
Other Biology News:Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 2Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 3Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 4Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 5Famous fossil Lucy scanned at the University of Texas at Austin 2Famous fossil Lucy scanned at the University of Texas at Austin 3
Rabbit IgG ELISA Development Kit, SensiFlex with Fluorocillin Green 495/525 from Molecular Probes (Invitrogen)
Human TNF-alpha from BioVision
Mouse Anti-Bovine WC1 Monoclonal Antibody, FITC Conjugated from AbD Serotec
...ns the basic components required for the developme...binant Feline IL-10 in cell culture supernates and...run ELISAs on approximately fifteen 96-well plates... The assay is run as summarized in the General ELI...
Biology Products: